Pharmafile Logo
Pharmafocus logo
Advanced Search

Trial data sounds death knell for Iressa

December 21, 2004
Sales and Marketing

AstraZeneca has effectively given up on its cancer drug Iressa, admitting that data from a new large scale trial shows …

News

FDA recommends alternatives following Celebrex scare

December 21, 2004
Sales and Marketing

A new study linking Celebrex to the same increased risk of heart attacks and strokes as recently withdrawn Vioxx has …

News

Watchdog intervenes to sack foundation trust chairman

December 20, 2004

News

AstraZeneca looks to Iressa successor after setback

December 16, 2004
Research and Development

AstraZeneca says it is optimistic about two of its most advanced cancer pipeline drugs, which it hopes will  offset a …

News

Restructured Takeda to go it alone on hypertension drug

December 16, 2004

Takeda is to assume full control of marketing hypertension drug candesartan in the UK from January, ending a seven-year collaboration …

News

Payments by Results could bankrupt hospitals, say doctors’ leaders

December 16, 2004

NHS hospitals that fail to attract patients could become bankrupt under the Payments by Results system, doctors' leaders have warned.Due …

News

Academics raise alarm over trial costs

December 15, 2004

Leading UK academic researchers say extra costs and bureaucracy from new European laws are killing off their work, and have …

News

Taking the plunge

December 10, 2004

When prompted to do some forward thinking, I often start by looking back. In 1999 I was an evangelist for …

Feature

Bextra to carry new safety warnings in US

December 10, 2004

Pfizer’s painkiller Bextra will have to carry stronger warnings in the US about increased risk of potentially fatal skin reactions …

News

inChord buys Junction 11 advertising agency

December 10, 2004
Medical Communications Junction 11, comms, inVentiv Health

 Global healthcare communications company inChord Communications has expanded its European base by buying the UK Junction 11 agency.inChord has its …

News

Chiron manufacturing ban extended

December 10, 2004

Chiron is facing a further three-month ban on vaccine production at its Liverpool factory, after problems were first detected by …

News

Efexor singled out in antidepressant safety review

December 7, 2004

A long-awaited investigation into the safety of modern antidepressants has concluded that the SSRI class of drugs is safe, but …

News

NHS star ratings to be scrapped

December 6, 2004

News

Have you perfected the work/life balance?

December 3, 2004

Perfecting the balance between work and the rest of life is increasingly a concern for employees and employers – based …

News

New five-year R&D strategy aims to increase investment

December 3, 2004

News

AZ to invest

December 3, 2004

News

First ‘super surgery’ opens its doors

December 3, 2004

News

Life-saving licence to boost Diovan

December 2, 2004

Sales of Novartis' hypertension treatment Diovan look set to increase following the granting of a new European Union licence for …

News

Cegedim service provides ‘integrated picture’ of markets

December 1, 2004

Pharmaceutical marketing data specialist Cegedim has launched a suite of new services to help pharma companies better understand their customers …

News

Breakthrough MS drug tipped for blockbuster status

November 30, 2004

The US has approved Tysabri, an innovative new drug which could offer new hope for sufferers of multiple sclerosis and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026